Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pfizer
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 5 ans
A study to assess the efficacy, safety and tolerability of PF-04950615 following monthly and twice monthly injection dosing for six months in subjects on a statin with high cholesterol
To evaluate the LDL-C lowering effect of PF-04950615 administered subcutaneously at monthly intervals, or twice monthly intervals in hypercholesterolemic subjects whose LDL-cholesterol is ≥80 mg/dL on...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 5 ans
A study to find out if a vaccine designed to protect against a disease (group B meningococcal meningitis) is safe and protects children aged from 24 months to less than 10 years
•To describe the immune response as measured by hSBA performed with 4 primary MnB test strains, 2 expressing an LP2086 subfamily A protein and 2 expressing an LP2086 subfamily B protein, measured 1 mo...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Pharma GmbH
Update Il y a 5 ans
Phase 2, single arm study of ticilimumab in patients with refractory metastatic adenocarcinoma of the colon or rectum
To assess the best overall response rate per RECIST (BRR) in patients with metastatic adenocarcinoma of the colon or rectum treated with ticilimumab
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer, S. A
Update Il y a 5 ans
A 102-Week, open label, multicenter trial to investigate the efficacy of macugen for the preservation of visual function in subjects with neovascular age-related macular degeneration (AMD) and to assess the benefit of treating early choroidal neovascularization (CNV)
To assess the efficacy of Macugen 0.3 mg for the preservation of vision in subjects with early CNV lesions and established CNV lesions.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Pfizer
Update Il y a 5 ans
B2151005 : Etude de phase 2 randomisé, évaluant l’efficacité de l’irinotecan associé au PF-05212384 ou au cétuximab, chez des patients ayant un cancer colorectal métastatique de type KRAS et NRAS sauvage. [essai suspendu] [essai clos aux inclusions]
L’objectif de cet essai est de comparer l’efficacité du PF-05212384 à celle du cétuximab associé à de l’irinotecan, chez des patients ayant un cancer colorectal métastatique de type KRAS et NRAS sauva...
Country
France
organs
Côlon ou Rectum (colorectal)
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Man Max 99 years
Pfizer Limited
Update Il y a 5 ans
A randomized double blind, placebo controlled balanced 4-way crossover study to assess the efficacy of single oral doses of PF-00592379 on erectile function, using 100mg sildenafil as a positive control
To assess the efficacy of single oral doses of PF-00592379 in improving penile erectile activity in subjects with MED.
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Pfizer Pharma GmbH
Update Il y a 5 ans
Randomized, Double-Blind Study of the morphine-sparing efficacy and safety of Parecoxib sodium 40 mg i.v. followed by 20 mg i.v. every 12 hours in the treatment of pain following radical prostatectomy
The primary objective of this study is to demonstrate the opioid-sparing efficacy of parecoxib 40 mg i.v. given as a loading dose followed by 20 mg i.v. in the 24 hours after the end of surgery.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc
Update Il y a 5 ans
A six-month, open-label outpatient, parallel group trial assessing the impact of inhaled insulin (Exubera®) on glycemic control in patients with type 2 diabetes mellitus who are poorly controlled on two oral anti-diabetic agents
The primary objective is to compare the efficacy between subjects who are treated with the combination of OHA’s and Exubera® compared to subjects treated with usual diabetes care, by looking at the me...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer, S. A
Update Il y a 5 ans
A Phase 3, Randomized Study of SU011248 versus Interferon-a as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
To compare the time to tumor progression (TTP) associated with SU011248 versus that associated with IFN-a for the first-line treatment of patients with metastatic renal cell carcinoma
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Pfizer Pharma GmbH
Update Il y a 5 ans
A multi-center, parallel group flexible dose study with a double blind, randomized, placebo controlled phase and an open-label phase to evaluate the quality of erections in men with erectile dysfunction treated with Sildenafil citrate
The study objective is to evaluate the effect that sildenafil citrate has on the hardness of erections in males with erectile dysfunction, based on subject responses to question 5 on the Event Log (ha...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
15
16
17
18
19
20
21
22
23
24
Next